We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,130.00
Bid: 4,926.00
Ask: 3,284.00
Change: 25.00 (0.61%)
Spread: -1,642.00 (-33.333%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4,105.00
ULVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Buy-Back Programme completes

3 Dec 2021 15:37

RNS Number : 5726U
Unilever PLC
03 December 2021
 

Unilever completes share buyback programme

3 December 2021

 

London - Unilever PLC announces the successful completion of the second tranche of its share buyback programme initially announced on 29 April 2021 (the 'Second Tranche'). Under the Second Tranche, which began on 23 August 2021, 32,508,415 Unilever PLC shares were purchased with a total value equivalent of approximately €1,499,999,934.

 

Under the first tranche of this buyback programme, which began on 6 May 2021 and completed on 13 August 2021, 30,467,730 Unilever PLC shares were purchased.

 

All of the shares purchased in the buyback programme have been placed in treasury. As a result, Unilever PLC holds a total of 62,976,145 shares in treasury and has a total of 2,566,267,627 non-treasury shares in issue. Of the non-treasury shares in issue, a total of 5,301,252 shares (including shares represented by Unilever PLC ADSs) are held by or on behalf of companies in the Unilever group (the 'Unilever Group Shares'). The voting rights attaching to the Unilever Group Shares are not exercisable.

 

With the completion of the Second Tranche, Unilever has delivered on its intention, as announced on 29 April 2021, to buy back shares with an aggregate market value equivalent of up to €3 billion.

 

Please see the total voting rights announcement dated 1 December 2021 for Unilever PLC's latest total voting rights figure published under the UK Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.

 

 

Unilever PLC

Unilever House100 Victoria EmbankmentLondon EC4Y 0DYUnited Kingdom

Press-Office.London@Unilever.com

 

 

CAUTIONARY STATEMENT

 

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the 'Group'). They are not historical facts, nor are they guarantees of future performance.

 

Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: Unilever's global brands not meeting consumer preferences; Unilever's ability to innovate and remain competitive; Unilever's investment choices in its portfolio management; the effect of climate change on Unilever's business; Unilever's ability to find sustainable solutions to its plastic packaging; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in our supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters. A number of these risks have increased as a result of the current Covid-19 pandemic. These forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

 

Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2020 and the Unilever Annual Report and Accounts 2020 available on our corporate website. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBUBDDSXGDGBX
Date   Source Headline
23rd Mar 202311:47 amRNSDirector/PDMR Shareholding
22nd Mar 20235:06 pmRNSTransaction in Own Shares
21st Mar 20234:52 pmRNSTransaction in Own Shares
20th Mar 20234:54 pmRNSTransaction in Own Shares
20th Mar 20232:59 pmRNSNotice of AGM
17th Mar 20235:06 pmRNSTransaction in Own Shares
17th Mar 20234:31 pmRNSDirector/PDMR Shareholding
17th Mar 20237:45 amRNSShare Buy-Back Programme
14th Mar 20234:06 pmRNSDirector/PDMR Shareholding
13th Mar 20236:20 pmRNSAnnual Report on Form 20-F
10th Mar 20235:47 pmRNSDirector/PDMR Shareholding
9th Mar 20236:22 pmRNSAnnual Financial Report
3rd Mar 202310:49 amRNSTotal Voting Rights
2nd Mar 20239:19 amRNSDirectorate Change
17th Feb 20234:38 pmRNSDirector/PDMR Shareholding
14th Feb 20235:51 pmRNSDirector/PDMR Shareholding
10th Feb 20236:03 pmRNSDirector/PDMR Shareholding
10th Feb 20234:49 pmRNSDirector/PDMR Shareholding
9th Feb 20237:00 amRNSFinal Results
2nd Feb 20231:22 pmRNSTotal Voting Rights
30th Jan 20237:00 amRNSDirectorate Change
13th Jan 202312:06 pmRNSPDMR Shareholding
4th Jan 202312:59 pmRNSTotal Voting Rights
20th Dec 20223:07 pmRNSPDMR Shareholding
19th Dec 20225:48 pmRNSDirector/PDMR Shareholding
19th Dec 20225:45 pmRNSShare Buyback Programme
19th Dec 20225:38 pmRNSTransaction in Own Shares
16th Dec 20226:05 pmRNSTransaction in Own Shares
15th Dec 20226:07 pmRNSTransaction in Own Shares
15th Dec 20225:35 pmRNSDirector/PDMR Shareholding
15th Dec 20223:04 pmRNSBlock listing of Shares
14th Dec 20226:12 pmRNSTransaction in Own Shares
13th Dec 20226:02 pmRNSTransaction in Own Shares
13th Dec 20223:59 pmRNSDirector/PDMR Shareholding
13th Dec 20222:40 pmRNSDirector/PDMR Shareholding
12th Dec 20225:51 pmRNSTransaction in Own Shares
12th Dec 202212:47 pmRNSDirector/PDMR Shareholding
9th Dec 20225:28 pmRNSTransaction in Own Shares
8th Dec 20226:14 pmRNSTransaction in Own Shares
7th Dec 20226:05 pmRNSTransaction in Own Shares
7th Dec 20224:54 pmRNSCapital Markets Day
6th Dec 20226:01 pmRNSTransaction in Own Shares
5th Dec 20225:53 pmRNSTransaction in Own Shares
2nd Dec 20226:10 pmRNSTransaction in Own Shares
2nd Dec 20225:38 pmRNSDirector/PDMR Shareholding - Replacement
1st Dec 20225:43 pmRNSTransaction in Own Shares
1st Dec 202211:12 amRNSTotal Voting Rights
30th Nov 20225:55 pmRNSTransaction in Own Shares
29th Nov 20226:02 pmRNSTransaction in Own Shares
23rd Nov 202210:55 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.